SCHEMBL31039740

SCHEMBL31039740

COC(C)CN1CCC[C@@H](Nc2nnc(Cl)c(C)n2)C1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 6/20 0.44
CCNK O75909 2/20 0.38
CDK7 P50613 2/20 0.38
CCNH P51946 2/20 0.38
MNAT1 P51948 2/20 0.38
CDK12 Q9NYV4 2/20 0.38
KAT2B Q92831 2/20 0.35
ROCK2 O75116 4/20 0.34
CCNT1 O60563 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
CDK9 P50750 1/20 0.34
IL1B P01584 2/20 0.33
CAMK2D Q13557 2/20 0.33
TNF P01375 1/20 0.33
ROCK1 Q13464 2/20 0.32
EHMT2 Q96KQ7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24695702 0.83 CAMK2D (0.45) NLRP3KAT2BIL1BCAMK2D
SCHEMBL29159546 0.83 CAMK2D (0.45) NLRP3KAT2BIL1BCAMK2D
SCHEMBL31039735 0.82 KAT2B (0.53) NLRP3CCNKCDK7CCNHMNAT1
SCHEMBL31341807 0.81 ROCK2 (0.45) NLRP3KAT2BROCK2CAMK2DROCK1
SCHEMBL27292457 0.80 NLRP3 (0.55) NLRP3CCNKCDK7CCNHMNAT1
SCHEMBL31039762 0.78 NLRP3 (0.56) NLRP3CCNKCDK7CCNHMNAT1
SCHEMBL31039733 0.78 NLRP3 (0.41) NLRP3CCNKCDK7CCNHMNAT1
SCHEMBL31341805 0.77 NLRP3 (0.40) NLRP3CCNKCDK7CCNHMNAT1
SCHEMBL25294649 0.76 KAT2B (0.45) NLRP3CCNKCDK12KAT2BCCNT1
SCHEMBL25294648 0.76 KAT2B (0.45) NLRP3CCNKCDK12KAT2BCCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630417-A1 NOVEL COMPOUNDS AS MODULATORS OF NLRP3 INHIBITION F. Hoffmann-La Roche AG (CH) 2025-10-15 EP disclosed
WO-2024121086-A1 NOVEL COMPOUNDS AS MODULATORS OF NLRP3 INHIBITION F. HOFFMANN-LA ROCHE AG (CH) 2024-06-13 WO disclosed